Calvin Darden's most recent trade in Aramark was a trade of 49 Common Stock done . Disclosure was reported to the exchange on June 9, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Aramark | Calvin Darden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 49 | 16,799 (0%) | 0% | 0 | Common Stock | |
Target Corp | Calvin Darden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 1,004 | 36,497 (0%) | 0% | 0 | Common Stock | |
Aramark | Calvin Darden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 45 | 16,749 (0%) | 0% | 0 | Common Stock | |
Aramark | Calvin Darden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 4,518 | 16,704 (0%) | 0% | 0 | Common Stock | |
Aramark | Calvin Darden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 35 | 12,186 (0%) | 0% | 0 | Common Stock | |
Cardinal Health, Inc. | Calvin Darden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 39,616 (0%) | 0% | 0 | Common Shares | |
Aramark | Calvin Darden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2020 | 45 | 12,151 (0%) | 0% | 0 | Common Stock |